The growing societal acceptance of cannabis in the U.S. has sparked what some call a "green rush" of people trying to cash in on what is already a multi-billion-dollar business. And as the marijuana industry comes out of the shadows, its producers, consumers and advocates are pushing for more transparency – both about cannabis' alleged medical benefits and its environmental impacts.
If D.C. residents vote to legalize marijuana possession next week, it wouldn’t just mean a sea change in drug policy in the nation’s capital. It could also mean big business. A study by District financial officials shared with lawmakers estimates a legal D.C. cannabis market worth $130 million a year. The ballot initiative voters will see Tuesday does not allow for the legal sale of marijuana — only the possession and home cultivation of small amounts — but D.C. Council members gathered Thursday to hear testimony about what a legal sales regime might look like.
Vigorous regulation of a thriving medical-marijuana industry in Colorado offers the best glimpse of what is coming to Washington when it launches its voter-approved social-use market. With continuous surveillance, bar-coded plants and strict financial background checks, Colorado's rules allowed capitalism to be unleased, creating an instant $200 million industry. With retail prices — averagingabout $7.50 a gram — among the cheapest in the country.
Executive Chairman of Medicanja, Dr Henry Lowe, is urging a spirit of cooperation between government ministries and agencies involved in the development of Jamaica's ganja industry, following the passage of the Decriminalisation Bill.
Last week, NBC’s Today Show giddily announced an exclusive: Privateer Holdings, the Seattle marijuana company long acclaimed locally for its straight, corporate image and Ivy-League-educated bosses, was launching “the first global pot brand” based on the legacy of Bob Marley. The company is likely to start selling pot overseas, says Privateer public-relations director Zack Hutson, previously a spokesperson for Starbucks. “We’re in discussions with a distributor in Israel” – a country with a federally legal medical-marijuana system. Hutson also cites Uruguay and the Netherlands as potential early markets.
British Columbia’s multibillion-dollar marijuana industry could take a “significant” blow now that two U.S. states – including its closest neighbour to the south – have voted to legalize marijuana. “The outcome of these votes in Washington State and Colorado is going to be a significant factor for this industry here in British Columbia,” Werner Antweiler, a professor at the University of B.C.’s Sauder School of Business, said in an interview Wednesday.
Votes in Washington and Colorado last month to legalize pot for recreational use turbocharged marijuana as a legitimate business opportunity. Business people packed a marijuana-industry conference in Denver the day after the election, and shares of publicly-traded companies spiked — one that sells marijuana vending machines jumped 3,000 percent.
Many Washington residents are looking to cash in on the newly legal and potentially lucrative marijuana market, which they hope will give them a new start, create jobs, and boost Washington's slumping economy. A diverse bunch, prospective marijuana entrepreneurs range from cannabis novices to experienced sellers crawling out of the black market. State officials are unsure how much revenue marijuana will bring because the market has never been regulated. But experts predict the industry could fetch up to $2bn over a five-year period.
Seattle's first-ever Medical Cannabis Cup — part gourmet weed contest, part trade show, part smoke-in — showcased the entrepreneurial drive and explosive growth of the local medical-marijuana industry. From dispensaries offering dozens of marijuana varieties to new potency-testing labs to makers of cannabis-infused capsules and candy corn, storefronts displaying the trademark green cross dot nearly every Seattle neighborhood. The city estimates there are at least 150 marijuana-related businesses here, more ubiquitous than Starbucks.
The cannabis industry is an easy target for legislatures to saddle with heavy taxes. In Washington State for instance, there is a 25% tax at three different stages of cannabis production: from the grower to the processor, from the processor to the retailer, and the retailer to the customer. These taxes are in addition to any other state or local sales taxes that might apply. Oregon Representative Earl Blumenauer, for instance, has introduced marijuana reform legislation that would enact a 50% excise tax on production.
Despite strong ministerial and legislative signals, segments of the marijuana lobby are unsure that sufficient protections will be afforded to the persons who currently supply the raw material. The challe
The exponential proliferation of the number of associations, clubs and other groups that distribute cannabis among their members and create new spaces for socialising, has surprised even the most optimistic advocates of more reasonable drug policies. In a short time, and in spite of those in government, civil society has provided a response to a problem that realpolitik has been unable to tackle.
Traditional small ganja farmers in Jamaica, accustomed to clandestinely working their fields, will now have to adhere to strict regulations in order to supply research institutions that have been granted licences.
A handful of legislators recently drew up a letter raising questions and concerns about the law, including whether it can be implemented by December as required under voter-approved Initiative 502. Alison Holcomb, drug-policy director for the ACLU of Washington and one of the law’s sponsors, defended it in a point-by-point response to the letter. Holcomb also implied that some of Hurst’s concerns could lead to a “Big Marijuana” industry whose advertising targets young people.
Washington state’s chief pot consultant remains a bit mysterious, but Mark Kleiman's views on legalizing pot are no mystery. He lays them out in “Marijuana Legalization,” a 2012 book he wrote with three of his team members. Alison Holcomb, the law’s author, said Kleiman’s credentials could ease federal concerns about Washington’s system evolving into an industry that tries to create addictions and market to young people. “I’m glad Kleiman and his colleagues are heading up the consulting group,” she said. (See also: Washington touts credentials of new pot consultant)